DNA Vaccines 2004 Second Circular and Provisional Conference Program

DNA Vaccines 2004
The Gene Vaccine Conference

17-19 November 2004
The Grimaldi Forum, Monte Carlo, Monaco

Advisory Scientific Panel

Conference Chairman: David Weiner (University of Pennsylvania, USA)

Maurizio Zanetti (University of California, San Diego, USA)
Lorne Babiuk (VIDO, Saskatchewan, Canada)
Eyal Raz (University of California, San Diego, USA)
Jim Robertson (NIBSC, Potters Bar, UK)
Jeffrey Ulmer (Chiron, California, USA)
Britta Wahren (Karolinska Institute, Stockholm, Sweden)
Constantin Bona (Mount Sinai School of Medicine, New York, USA)
Joel Haynes (Powderject Vaccines, Madison, USA)
Freda Stevenson (Tenovus Laboratory, Southampton, UK)

DNA VACCINES 2004 is the follow-up meeting to the successful DNA VACCINES 2002 conference held in Edinburgh in October 2002.

From an unproven novelty with limited acceptance in the community, DNA or ‘Genetic’ vaccines have arrived as a potent means of providing immune responses or protective immunity against viruses, bacteria and parasites in many species from fish to primates, including human volunteers. DNA vaccines, comprising plasmid DNA encoding proteins from pathogens, allergens, and tumours, are being evaluated as prophylactic vaccines and therapeutic treatments for infectious diseases, allergies and cancer. Plasmids encoding normal human proteins are likewise being tested as vaccines and treatments for autoimmune diseases.

DNA vaccination has become an accepted method in the research community with human trials now in process. The use of DNA as a means of vaccination offers potential benefits in protective efficacy, cross-strain applicability, development speed and manufacturing cost compared with conventional vaccines. DNA vaccines are known to be particularly effective in inducing killer T-cell responses which are an important ingredient in fighting infections.

DNA VACCINES 2004 will follow-up the success of the 2002 Edinburgh meeting in attracting delegates from the cancer and the infectious disease communities to come together to discuss the ‘common ground’ between these two major groups.

DNA VACCINES 2004 will again be major opportunity for leading researchers to gather and report on the latest cutting edge research currently being undertaken in the progressive field of DNA or Genetic Vaccines.

Closing date for poster abstract submissions Friday 1st October 2004